Back
Mesoblast 10K Form
Sell
46
MESO
Mesoblast
Last Price:
10.12
Seasonality Move:
10.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MESO News And Ratings
See the #1 stock for the next 7 days that we like better than MESO
MESO Financial Statistics
Sales & Book Value
| Annual Sales: | $5.9M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.85 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 53.01760 |
|---|---|
| Net Income (TTM): | $-81.89M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Mesoblast Earnings Forecast
Key Mesoblast Financial Ratios
- The Research & Development expenses have been 429.57% of Revenue.
- The Interest Expense is -23.49% of Operating Income.
- The Net Earning history of MESO is -1,490.27% of Total Revenues.
- Per Share Earnings over the last 20 years have been positive in 8 years.
Mesoblast Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MESO |
| CUSIP: | 590717 |
| Website: | mesoblast.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |